IntelGenx Technologies Corp (IGXT)

[RobertJames]

IntelGenx (TSX-V:IGX) (OTCQX:IGXT) to Host Management Call



SAINT LAURENT, Quebec, July 18, 2014 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that its interim CEO, Dr. Horst G. Zerbe, will be hosting a conference call on July 23rd, 2014 at 10:00 AM Eastern Time.

During the conference call, Dr. Zerbe will provide a business update and discussion regarding the Company's recent management changes. After management's comments, the call will be opened for questions.

An accompanying webcast will also be provided. Please refer to the information below for conference call dial-in information and webcast registration.

Conference dial-in: 877-269-7756
International dial-in: 201-689-7817 7817
Conference Call Name: IntelGenx Management Update Call
Webcast Registration: CLICK HERE (http://w.on24.com/r.htm?e=827651&s=1&k=32D198D6AB7E398E72BDE0D6DF0CB7CC)

Following the live call, a replay will be available on the Company's website, www.intelgenx.com, under "Investor Relations".

About IntelGenx:

IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products. More information is available about the company at www.intelgenx.com.